Samuel Frank
Overview
Explore the profile of Samuel Frank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirk P, Qamar P, Zugman A, Abend R, Frank S, Ringlein G, et al.
Hum Brain Mapp
. 2025 Mar;
46(4):e70163.
PMID: 40042099
Movie-watching fMRI has emerged as a theoretically viable platform for studying neurobiological substrates of affective states and emotional disorders such as pathological anxiety. However, using anxiety-inducing movie clips to probe...
2.
Frank S, Testa C, Goldstein J, Kayson E, Leavitt B, Oakes D, et al.
CNS Drugs
. 2025 Jan;
39(2):185-195.
PMID: 39825184
Background: Huntington disease (HD) is a progressive neurodegenerative disease that causes psychiatric and neurological symptoms, including involuntary and irregular muscle movements (chorea). Chorea can disrupt activities of daily living, pose...
3.
Beylergil S, Mukunda K, Elkasaby M, Perlmutter J, Factor S, Baumer T, et al.
Dystonia
. 2024 Nov;
3.
PMID: 39512809
Background: Cervical dystonia (CD) is the most common form of focal dystonia encountered in the clinic. Approximately one-third of CD patients have co-existing tremor in the head and hands. Assessment...
4.
Laabs B, Lohmann K, Vollstedt E, Reinberger T, Nuxoll L, Kilic-Berkmen G, et al.
Mov Disord
. 2024 Sep;
39(11):2110-2116.
PMID: 39287592
Background: Despite considerable heritability, previous smaller genome-wide association studies (GWASs) have not identified any robust genetic risk factors for isolated dystonia. Objective: The objective of this study was to perform...
5.
Frank S, Anderson K, Fernandez H, Hauser R, Claassen D, Stamler D, et al.
Neurol Ther
. 2024 Sep;
13(6):1747-1749.
PMID: 39266813
No abstract available.
6.
Kilic-Berkmen G, Scorr L, McKay L, Thayani M, Donsante Y, Perlmutter J, et al.
Mov Disord Clin Pract
. 2024 May;
11(8):973-982.
PMID: 38778444
Background: Prior studies have indicated that female individuals outnumber male individuals for certain types of dystonia. Few studies have addressed factors impacting these sex differences or their potential biological mechanisms....
7.
Sierra L, Wynn A, Lanzaro E, Dzekon K, Russell A, Halko M, et al.
J Huntingtons Dis
. 2024 May;
13(2):249-257.
PMID: 38759020
Background: Huntington's disease (HD) is a neurodegenerative disorder marked by cognitive impairment, movement abnormalities, and behavioral disturbances. The Stroop Color Word Test (SCWT) is a widely used tool to detect...
8.
Anderson K, Arbatti L, Hosamath A, Feigin A, Goldstein J, Kayson E, et al.
J Huntingtons Dis
. 2024 May;
13(2):237-248.
PMID: 38701155
Background: Direct-to-participant online reporting facilitates the conduct of clinical research by increasing access and clinically meaningful patient engagement. Objective: We assessed feasibility of online data collection from adults with diagnosed...
9.
Frank S, Anderson K, Fernandez H, Hauser R, Claassen D, Stamler D, et al.
Neurol Ther
. 2024 Apr;
13(3):655-675.
PMID: 38557959
Introduction: Deutetrabenazine is a vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia (TD) and chorea associated with Huntington disease (HD). To enhance detection of safety signals across individual...
10.
Boz D, Kilic-Berkmen G, Perlmutter J, Norris S, Wright L, Klein C, et al.
Mov Disord Clin Pract
. 2023 Dec;
10(12):1777-1786.
PMID: 38094647
Background: There are several widely used clinical rating scales for documenting the severity and distribution of various types of dystonia. Objectives: The goal of this study was to evaluate the...